Kidney transplant patients have a higher risk of death from Covid-19 and low vaccine protection

Out of a total of 486 transplant patientsmost renal, 125 have died from Covid-19that is to say that the mortality in the population of transplant recipients who fall ill with SARS CoV2 is 25%, said Dr. Victor Hugo Ahumada Topeteinternist infectologist attached to the National Institute of Respiratory Diseases (descends)

“Within immunosuppressed patients, kidney transplant patients are one of the groups with the highest risk of death from Covid,” said the specialist.

You might be interested in: More than half of Health resources attend chronic non-communicable diseases: Ssa

In the framework of world kidney daythe doctor Smoked Topetehighlighted that vaccination against Covid in transplant patients reaches an efficiency of only 45%.

He explained that while the application of vaccines to hemodialysis patients reached 89% efficiencythe transplanted barely reached the 35% protection with two doses.

“Kidney transplant patients need special vaccination guidelines because the immunity that is generated in this group after vaccination is not optimal at all.” he commented she.

The transplant patients kidney stones are of those less immune protection mount after the vaccines, compared to other bone marrow transplant recipients or others”, he referred.

He said that the immunosuppression that kidney transplant patients suffer from is very intense and makes the protection immunological by the vaccine is very low.

You might be interested in: Fan who saves his eye after violence at the Corregidora Stadium, thanks IMSS for attention

Meanwhile, studies conducted in United Statespointed out that after three doses of the vaccine, the protection reached 68% “That means that the 32% of patients transplanted after receiving three doses of Pfizer O Modernthey did not have the expected response in antibody levels.”

Therefore, kidney transplant patients require special vaccine guidelines, hence the Centers for Disease Control and Prevention (CDC) in the United States, is recommending a schedule of three initial doses and a booster dose, that is, four doses for this group of the population.

LEO

Related